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We describe the case of a 47-year-old Caucasian male patient who developed sarcoidosis 18 months after
he was diagnosed with pulmonary tuberculosis for which he was treated according to guidelines. The
presentation of sarcoidosis was very similar to his ﬁrst presentation when he was diagnosed with
tuberculosis.
Mycobacterium tuberculosis as a possible aetiological agent in sarcoidosis has been point of debate
since many years and has been studied thoroughly. Recent advances in immunologic and molecular
techniques have strengthened the association between mycobacteria and sarcoidosis.1
Sarcoidosis is a systemic inﬂammatory disorder of unknown aetiology, characterised by the presence
of non-caseating epitheloid cell granulomas. It is generally agreed that this is a tissue reaction to envi-
ronmental agents in a genetically susceptible individual.2 Tuberculosis is an infectious disease caused by
M. tuberculosis and characterised by caseating granulomas. In both clinical and histopathological features
sarcoidosis is remarkably similar to tuberculosis and therefore can be difﬁcult to distinguish.
First, this case report demonstrates the need of diagnostic testing when reactivation of tuberculosis is
suspected. And second the role of M. tuberculosis in the aetiology of sarcoidosis will be discussed.
 2013 Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
Sarcoidosis is a systemic inﬂammatory disorder of unknown
aetiology, characterised by the presence of non-caseating epi-
theloid cell granulomas. It is generally agreed that this is a tissue
reaction to environmental agents in a genetically susceptible indi-
vidual.2 Tuberculosis is an infectious disease caused by Mycobac-
terium tuberculosis and characterised by caseating granulomas. In
both clinical and histopathological features sarcoidosis is remark-
ably similar to tuberculosis and therefore can be difﬁcult to
distinguish.
M. tuberculosis as a possible aetiological agent in sarcoidosis has
been point of debate since many years and has been studied thor-
oughly. Recent advances in immunologic and molecular techniques
have strengthened the association between mycobacteria and
sarcoidosis.1
Herein we demonstrate the need of diagnostic testing when
reactivation of tuberculosis is suspected. Furthermore the role ofM.
tuberculosis in the aetiology of sarcoidosis will be discussed.nschot).
-NC-ND license.2. Case presentation
A 47-year-old male with no medical history was referred to the
St. Catharins Hospital (Eindhoven, the Netherlands) in May 2010
following a two-week history of fever and dyspnoea. Therewere no
complaints of cough and no history of smoking. His mother died in
an other hospital three months before this episode due to an un-
known pulmonary infection.
On physical examination, the patient was dyspnoeic with 24
breaths per minute and an oxygen saturation of 88% on ambient air.
His blood pressure was 115/70 mmHg with a heart rate of
105 beats/min. Body temperature was 38.8 degrees Celsius. Apart
from bilateral inspiratory ﬁne crackles no other physical abnor-
malities were observed.
Laboratory investigations showed a mild normocytic anaemia
(haemoglobin 7.9mmol/L), white blood count 3.7/nL and C-reactive
protein 200 mg/L. Alanine-aminotransferase, aspartate-amino-
transferase, alkalic phosphatase and gamma-glutamyl-transferase
were all raised tenfold the upper limit. Serum electrolyte levels
and renal function indices were normal.
Arterial gas analysis indicated pH 7.42, pO2 32 mmHg, pCO2
74 mmHg and bicarbonate 20.4 mmol/L.
Chest X-ray on admission disclosed bilateral consolidations
(Fig. 1). Under suspicion of an atypical pulmonary infection
Fig. 1. Chest radiogram with diffuse bilateral reticular interstitial densities in the middle and lower lung lobes (left) and a normal chest radiogram after treatment (right).
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Direct smear microscopy examination of the sample and sputum
for the presence of acid-resistant bacilli by using Ziehl-Neelsen
method was negative. However the Polymerase Chain Reaction
(PCR) forM. tuberculosis complex (MTBC) DNAwas positive. Patient
was tested HIV negative and no signs of immunosuppressive dis-
orders were found.
During the ﬁrst day of hospitalisation the patient became res-
piratory insufﬁcient and tracheal intubation was necessary for ﬁve
days. Treatment was started with broad spectrum antibiotics and
on suspicion of a human tuberculosis infection standard anti-
tuberculosis drug regimen was started. (isoniazid (H) 300 mg
daily, rifampin (R) 600 mg daily, pyrazinamide (Z) 2000 mg daily,
ethambutol (E) 1600 mg daily and pyridoxin 600 mg daily). Three
weeks after admission the culture of the BAL ﬂuid was positive for
M. tuberculosis. Antibiogram showed a normal sensitivity pattern so
the ethambutol was discontinued. In total the patient was treated
with HRZ for two months followed by four months of HR.
14 days after initiating therapy sputum conversion was reached
as presence of acid-resistant bacilli by using Ziehl-Neelsen method
was negative in sputum sample, during 3 consecutive days. 10 Days
after discharge from the intensive care unit patient was discharged
from the ward. Clinical parameters all improved rapidly during his
treatment. Furthermore the liver enzymes normalised during his
hospital stay and remained normal during the total treatment
period.
One month after initiating treatment for tuberculosis patient
complained of lumbar back pain. Further radiologic evaluationFig. 2. Computed tomogram of the thorax showing mediastinal lymphadenopathusing MRI showed abnormal signal intensity of L4, which was
interpreted as spondylitis for which patient was referred to the
orthopaedic surgeon. No further actions were taken and complaints
resolved. At radiologic follow-up 3 months after MRI sclerosis was
seen, but no signs of spondylitis anymore.
After treatment of theM. tuberculosis infection no abnormalities
were seen on radiologic evaluation using X-ray of the chest, espe-
cially no parenchymal abnormalities or lymphadenopathy.
In November 2011 the patient was referred to the ophthalmol-
ogist by the general practitioner with complaints of red eye which
did not resolve with chloramphenicol. The ophthalmologist diag-
nosed uveitis and initiated treatment with ocular prednisolon and
atropine. Under this treatment uveitis resolved completely except
for remaining synechia. Under suspicion of reactivation of tuber-
culosis the patient was referred to our outpatient clinic. At that time
he had no pulmonary complaints, in particular no cough, weight
loss or dyspnoea. He did not appear to be ill with a blood pressure
of 115/70 mmHg, heart rate 105 beats/min and oxygen saturation
98% on ambient air. No physical abnormalities were observed. His
body temperature was 37.1 degrees Celsius.
Laboratory investigations showed normal electrolytes including
calcium and renal function. Erythrocyte sedimentation rate was
5 mm/h and C-reactive protein was <6.0 mmol/L. Angiotensin
converting enzyme was 86 U/L (normal range 12e82 U/L).
Chest radiogram disclosed suspicion of mediastinal and hilar
lymphadenopathy and interstitial densities in the right lobe
which was conﬁrmed on computed tomography of the thorax
(Fig. 2).y (left) and multiple nodules in the apical segment of the right upper lobe.
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lobe in combination with trans-bronchial needle aspiration (TBNA)
of a pretracheal lymph node. No acid-resistant bacilli were found in
the ﬂuid lavage or in the cytologic material of TBNA. PCR for M.
tuberculosis DNA was negative. Nevertheless since there was high
suspicion on reactivation of pulmonary tuberculosis anti-
tuberculosis drug therapy was initiated.
Two months following initiating treatment for M. tuberculosis
another computed tomogram of the thorax was performed which
was completely unchanged in comparison to the earlier scan,
except now there were multiple nodules located at the right major
ﬁssure.
An endoscopic ultrasound with ﬁne needle aspiration of a
subcarinal lymph node was performed. Microscopic analysis
revealed a population of lymphoid cells with spread granulomas.
Necrosis was not observed. PCR for MTBC DNA was negative and
acid-resistant bacilli were not present. Apart from the ﬁne needle
aspiration, a biopsy of an erythematosquamous lesion on the left
upper arm was taken which revealed granulomatous structures,
consisting of epitheloid histiocytes and few polynucleid giant cells,
surrounded by small atypic lymphocytes. No central necrosis or
caseiting was seen.
The patient was diagnosed with sarcoidosis and anti-
tuberculosis therapy was discontinued.
Cardiac magnetic resonance imaging revealed no cardiac
granulomas.
Diffusion capacity for carbon monoxide was normal and during
exercise testing no oxygen uptake problem could be observed.
As there was no indication for initiating immunosuppressive
therapy patient was seen at our outpatient clinic every three
months for follow-up.
3. Discussion
At ﬁrst presentation the patient was diagnosed with pulmonary
miliary tuberculosis. Because of the rapid deterioration, it was very
well possible that during admission at the hospital a bacterial su-
perinfection was present, although no other infectious agent was
determined. Treatment of the tuberculosis infectionwas performed
according to the standard anti-TB drug regimen. Directly observed
therapy (DOT) was performed during the six months therapy, so we
can assume adequate therapy was given, although randomized
controlled trials provide no assurance that the routine use of DOT
improves cure or treatment completion.3
18 months after his initial presentation the clinical features and
diagnostic imaging which was performed could very well be
matched with a reactivation of tuberculosis as uveitis and medi-
astinal lymphadenopathy in combination with nodules located in
the right upper lobe were present. The normal erythrocyte sedi-
mentation rate and no physical or respiratory complaints argue
with this statement. The ﬁrst TBNA that was performed during the
hospitalisation 12 months after discontinuation of the anti-
tuberculous therapy did not show lymphoid material meaning
the results of negative cultures and the absence of acid-resistant
bacilli as well as the negative PCR for MTB DNA should be taken
with caution.
Guided by the above-discussed results diagnosis of pulmonary
sarcoidosis and uveitis was the correct diagnosis.
The percentage of sarcoidosis patients with eye involvement
varies widely with approximately 30% in the United States of
America and England to approximately 70% in Japan.4 Uveitis is also
frequently seen in M. tuberculosis infection, so this does not
differentiate between sarcoidosis and tuberculosis.
The use of endobronchial ultrasound could have been consid-
ered in an earlier phase, as the TBNA was not representative. If thePCR for MTBC DNA and Ziehl-Neelsen were also negative discon-
tinuation of anti-TB drug therapy was justiﬁed earlier.
As stated in the introduction the role of mycobacteria in the
aetiology of sarcoidosis has been extensively studied. Initial studies
had focused on an epidemiological link and tried to demonstrate
presence of mycobacteria using cultures or histological evaluation.
More recent studies demonstrate that molecular assays can detect
genetic material from mycobacteria in sarcoidosis samples with
high sensitivity. Gazouli et al. reported that in a Greek sarcoidosis
population 72% of tissues contained ampliﬁable MTB DNA and
Saboor and colleagues found MTB DNA in half of sarcoidosis lung
samples using PCR.5,6
Furthermore, several studies using immune assays and the
isolation of antigens (e.g. Mycobacterial catalase-peroxidase anti-
gen, mKatG) have lead to a robust step in associating sarcoidosis
andmycobacteria. mKatGmay lead to a T-cell response which leads
to formation of granulomas and might therefore be a pathogenic
antigen.7 These studies may indicate that the presence of myco-
bacterial antigens is enough to elicit immune reaction in a sus-
ceptible host.
This might explain why only few case studies have been re-
ported where patients develop sarcoidosis after culture positive
tuberculosis and that the incidence of sarcoidosis is higher in
countries with high burden of latent tuberculosis. This fact also
highlights the limitations of serological and molecular studies to
discriminate between the two conditions.
4. Conclusion
M. tuberculosis and/or antigens very likely play a role in the
aetiology of sarcoidosis in a proportion of patients as recent ad-
vances in immunological and molecular techniques have
strengthened the association between mycobacteria and sarcoid-
osis.1,8 Further studies using new techniques could help in the
understanding of immune responses caused by mycobacterial an-
tigens and other possible infectious antigens.
This case report demonstrates that when recurrent disease of
tuberculosis is suspected one has to keep in mind a broad differ-
ential diagnosis as other similar presenting diseasesmay be present
which warrant a different approach for treatment. In the work-up
of diagnostics one should always be sure that cytologic or histo-
logic material is representative as this inﬂuences the interpretation
of the results.
Only two case studies have been reported where a patient who
was treated for tuberculosis developed sarcoidosis. One developed
a cutaneous sarcoidosis with uveitis and no pulmonary involve-
ment9 and the other one developed a miliary sarcoidosis.10
To our knowledge our patient is unique as he developed pul-
monary stage two sarcoidosis in combination with uveitis and
demonstrates a likely causative role of mycobacterial antigens in
the development of sarcoidosis.
Conﬂict of interest
There exists no conﬂict of interest.
References
1. Brownell I, Ramirez-Valle F, Sanchez M, Prystowksi S. Translational review,
evidence for mycobacteria in sarcoidosis. Am J Respir Cell Biol 2011;45:899e
955.
2. Baughman RP, Lower EE, du Bois RM. Sarcoidosis. Lancet 2003;361:1111e8.
3. Volmink J, Garner P. Directly observed therapy for treating tuberculosis.
Cochrane Database Syst Rev 2012;1. CD003343.
4. Baughman RP, Lower EE, Kaufman AH. Ocular sarcoidosis. Semin Respir Crit Care
Med 2010;31(4):452e62.
J.W.T. van Enschot, R.H.H. van Balkom / Respiratory Medicine Case Reports 9 (2013) 11e14145. Gazouli M, Ikonomopoulos J, Trigidou R, Foteinou M, Kittas C, Gorgoulos V.
Assessment of mycobacterial, propionibacterial, and human herpesvirus 8 DNA
in tissues of Greek patients with sarcoidosis. J Clin Microbiol 2002;40:3060e3.
6. SaboorSA, JohnsonNM,McFadden J.DetectionofmycobacterialDNA in sarcoidosis
and tuberculosis with polymerase chain reaction. Lancet 1992;339:1015e7.
7. Chen ES, Wahlstrom J, Song Z. T cell responses to mycobacterial catalase-
peroxidase proﬁle, a pathogenic antigen in systemic sarcoidosis. J Immunol
2008 Dec 15;181(12):8784e96.8. Gupta D, Agarwal R, Aggarwal AN, Jindal S. Review, sarcoidosis
and tuberculosis: the same disease with different manifestations or
similar manifestations of different disorders. Curr Opin Pulm Med 2012;18:
506e16.
9. Satyaki G, Dhiman G. Sarcoidosis following sputum positive pulmonary
tuberculosis: a rare entity. Indian J Dermatol 2012 Jan-Feb;57(1):76e8.
10. Hatzakis K, Siafaka NM, Bouros D. Miliary sarcoidosis following miliary
tuberculosis. Respiration 2000;67(2):219e22.
